Mark Emalfarb details emailed allegations at the heart of Dyadic International's $700-plus million legal malpractice trial against Greenberg Traurig.
West Palm Beach, FL—The CEO of a Florida biotech company told jurors last week he felt he was made into a scapegoat during a rush to judgment that allegedly cost his company $700 million in lost business, as trial continued in the company’s malpractice suit against legal giant Greenberg Traurig. Dyadic Inc. v. Greenberg Traurig, 2009CA010680.